[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX25231A - Compuestos de carbapenem y procedimiento para su preparacion. - Google Patents

Compuestos de carbapenem y procedimiento para su preparacion.

Info

Publication number
MX25231A
MX25231A MX2523191A MX2523191A MX25231A MX 25231 A MX25231 A MX 25231A MX 2523191 A MX2523191 A MX 2523191A MX 2523191 A MX2523191 A MX 2523191A MX 25231 A MX25231 A MX 25231A
Authority
MX
Mexico
Prior art keywords
procedure
preparation
carbapenem compounds
carbapenem
compounds
Prior art date
Application number
MX2523191A
Other languages
English (en)
Inventor
Scott Louis Dax
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX25231A publication Critical patent/MX25231A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX2523191A 1990-04-09 1991-04-05 Compuestos de carbapenem y procedimiento para su preparacion. MX25231A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50613590A 1990-04-09 1990-04-09

Publications (1)

Publication Number Publication Date
MX25231A true MX25231A (es) 1993-10-01

Family

ID=24013339

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2523191A MX25231A (es) 1990-04-09 1991-04-05 Compuestos de carbapenem y procedimiento para su preparacion.

Country Status (17)

Country Link
EP (1) EP0451764A1 (es)
JP (1) JPH04234884A (es)
AU (1) AU7420591A (es)
BR (1) BR9101418A (es)
CA (1) CA2039987A1 (es)
CS (1) CS94391A2 (es)
FI (1) FI911666A (es)
HU (1) HUT57769A (es)
IE (1) IE911161A1 (es)
IL (1) IL97797A0 (es)
MC (1) MC2262A1 (es)
MX (1) MX25231A (es)
NO (1) NO911357L (es)
PT (1) PT97287A (es)
TW (1) TW216420B (es)
YU (1) YU62991A (es)
ZA (1) ZA912279B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
ATE193890T1 (de) * 1990-04-18 2000-06-15 Procter & Gamble Pharma Antimikrobielle chinolonyl-lactame
ATE150463T1 (de) * 1991-10-01 1997-04-15 Procter & Gamble Pharma Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
EP0775145A1 (en) * 1994-08-02 1997-05-28 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
KR100242355B1 (ko) * 1994-08-02 2000-03-02 데이비드 엠 모이어 항미생물 화합물의 제조 방법
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
JP2001519773A (ja) * 1997-01-21 2001-10-23 メルク エンド カンパニー インコーポレーテッド カルバペネム中間体の合成プロセス
US6080854A (en) * 1997-08-25 2000-06-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
EP0366193A3 (en) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactams
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
EP0366641B1 (en) * 1988-10-24 2000-07-05 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactam esters

Also Published As

Publication number Publication date
EP0451764A1 (en) 1991-10-16
ZA912279B (en) 1992-02-26
YU62991A (sh) 1994-04-05
CA2039987A1 (en) 1991-10-10
IE911161A1 (en) 1991-10-09
NO911357D0 (no) 1991-04-08
CS94391A2 (en) 1991-11-12
TW216420B (es) 1993-11-21
HUT57769A (en) 1991-12-30
AU7420591A (en) 1991-10-10
MC2262A1 (fr) 1993-04-26
JPH04234884A (ja) 1992-08-24
FI911666A0 (fi) 1991-04-08
BR9101418A (pt) 1991-11-26
IL97797A0 (en) 1992-06-21
PT97287A (pt) 1992-01-31
FI911666A (fi) 1991-10-10
HU911132D0 (en) 1991-10-28
NO911357L (no) 1991-10-10

Similar Documents

Publication Publication Date Title
MX24568A (es) 3-arilcarbonil-1h-indoles y procedimiento para su preparacion.
MX20476A (es) Composiciones de polipropileno y procedimiento para su preparacion.
MX174176B (es) Compuestos azo y procedimiento para su preparacion
MX16687A (es) Compuestos de biarilo y procedimiento para su preparacion.
MX26267A (es) Aminobenzodiacepinas y procedimiento para su prepaacion.
MX22954A (es) Compuestos de quinolona y un procedimiento para su preparacion.
MX25231A (es) Compuestos de carbapenem y procedimiento para su preparacion.
MX9201780A (es) Eteres oximicos y procedimiento para su preparacion.
MX22255A (es) Compuestos de piridinil-quinolona y procedimiento para su preparacion.
MX9100743A (es) Compuestos heterociclicos y procedimiento para su preparacion
MX9205747A (es) Pirazolinas y procedimiento para su preparacion.
MX9201609A (es) Procedimiento para la hidrogenolisis de mezclas de halocarburos.
MX9205821A (es) Pirimidinil- y triazinileteres y -tioeteres y procedimiento para su preparacion.
MX9205746A (es) Pirazolinas y procedimiento para su preparacion.
MX9101794A (es) Compuestos de trifendioxazina y procedimiento para su preparacion
MX9100779A (es) Compuestos azabiciclicos y procedimiento para su preparacion
MX9102324A (es) Pirimidilamidoximas substituidas y procedimiento para su obtencion.
NO910181D0 (no) Fremgangsmaate for alkylering av hydrokinon.
MX9200120A (es) Compuestos de bipiridilo y procedimiento para su preparacion
MX9202250A (es) Compuestos de penem y procedimiento para su preparacion.
MX9200764A (es) Procedimiento para la preparacion de 3-hidroxipropanonitrilos 3-substituidos.
MX9201195A (es) Procedimiento para la realizacion de elementos de encuadernacion.
MX17550A (es) Compuestos de 1-carba(detia)cefalosporina y procedimiento para su preparacion.
MX15982A (es) Compuestos hidrosolubles de ftalocianina y procedimiento para su preparacion.
MX24796A (es) Fenilcetonas y procedimiento para su preparacion.